Skip to content

GENZYME BELGIUM

Absorbed by Sanofi-Aventis Belgium NV on 01-05-2012 KBO/BCE: BE 0453.475.493 subsidiary of .

Timeline

31 events since 1994
2012
Annual accounts 2011 filed PDFfull format · 21 days before the deadline
Merger: absorbed by SANOFI-AVENTIS BELGIUM PDFCapital €1,162,500, annual accounts 2011
, , and change roles holds all the shares · Legal-form conversion: from public limited company to private limited company (pre-2019) · Capital of €1,162,500, 23,250 shares11 points ▸
  • holds all the shares
  • Legal-form conversion, from public limited company to private limited company (pre-2019)
  • Capital, €1,162,500, 23,250 shares
  • Director resignation,
  • Director resignation,
  • Director resignation,
  • Director resignation,
  • Director appointment, (niet statutaire zaakvoerder van de besloten vennootschap met beperkte aansprakelijkheid)
  • Director appointment, (niet statutaire zaakvoerder van de besloten vennootschap met beperkte aansprakelijkheid)
  • Director appointment, (niet statutaire zaakvoerder van de besloten vennootschap met beperkte aansprakelijkheid)
  • Director appointment, (niet statutaire zaakvoerder van de besloten vennootschap met beperkte aansprakelijkheid)
  • The deed holds 7 more points.

Open the deed in the Belgian Official Gazette

2 directors appointed, 2 resignations and resign · and appointed · General meeting of 20-01-20125 points ▸
  • General meeting, 20-01-2012
  • Director resignation,
  • Director resignation,
  • Director appointment,
  • Director appointment,

Open the deed in the Belgian Official Gazette

New managing director appointed, resigned · Board meeting of 23-01-20123 points ▸
  • Board meeting, 23-01-2012
  • Director resignation, (managing director)
  • Director appointment, (managing director)

Open the deed in the Belgian Official Gazette

Merger proposal: to be absorbed by Sanofi-Aventis Belgium NVLegal-form conversion: from public limited company to private limited company (pre-2019) · . holds 23,249 shares · holds 1 share6 points ▸
  • Legal-form conversion, from public limited company to private limited company (pre-2019)
  • . holds 23,249 shares
  • holds 1 share
  • is a shareholder
  • Share issue, €2,492
  • Accounting effect, 01-01-2012
  • The deed holds 13 more points.

Open the deed in the Belgian Official Gazette

Merger proposal: to be absorbed by Sanofi-Aventis Belgium NV PDFCapital €1,162,500, annual accounts 2011
New managing director appointed, resigned · Board meeting of 10-12-20103 points ▸
  • Board meeting, 10-12-2010
  • Director resignation, (managing director)
  • Director appointment, (managing director)

Open the deed in the Belgian Official Gazette

reappointed as statutory auditorGeneral meeting of 13-05-20112 points ▸
  • General meeting, 13-05-2011
  • Auditor reappointment, (statutory auditor)
  • The deed holds 1 more point.

Open the deed in the Belgian Official Gazette

2011
Annual accounts 2010 filed PDFfull format · 38 days before the deadline
3 directors appointed, 3 resignations, and resign · , and appointed · General meeting of 10-12-20107 points ▸
  • General meeting, 10-12-2010
  • Director resignation,
  • Director resignation,
  • Director resignation,
  • Director appointment,
  • Director appointment,
  • Director appointment,

Open the deed in the Belgian Official Gazette

2010
Annual accounts 2009 filed PDFfull format · 32 days before the deadline
2009
Weakest financial year net €601,162 ▼28.9% The net result drops to €601,162, the lowest from 2007 to 2011.
Annual accounts 2008 filed PDFfull format · 3 days before the deadline
2008
Highest result from 2007 to 2011 net €845,406 ▲27% The net result of €845,406 is the highest of those years.
Annual accounts 2007 filed PDFfull format · 75 days late
2007
Equity above €2m equity €2.6m ▲133,973% Equity rises from €1,953 to €2.6m.
Annual accounts 2006 filed PDFfull format · 66 days late
Annual accounts 2005 filed PDFfull format · 211 days late
2005
Annual accounts 2004 filed PDFfull format · 17 days before the deadline
Annual accounts 2003 filed PDFfull format · 286 days late
2003
Annual accounts 2002 filed PDFfull format · 20 days before the deadline
2002
Annual accounts 2001 filed PDFfull format
2001
Annual accounts 2000 filed PDFfull format
2000
Annual accounts 1999 filed PDFfull format
1999
Annual accounts 1998 filed PDFfull format
1998
Annual accounts 1997 filed NBBfull format
1997
Annual accounts 1996 filed NBBfull format
1996
Annual accounts 1995 filed NBBfull format
1995
Annual accounts 1994 filed NBBfull format
1994
Incorporation 41 publications in the Belgian Official Gazette, the last on 15-05-2012

Financial milestones sit on the financial year-end date, not the filing date.

Sources: Publications in the Belgian Official GazetteFilings with the National Bank

History

GENZYME BELGIUM has filed 18 sets of annual accounts, the latest for financial year 2011.1 In 2012 the company was absorbed by merger into Sanofi-Aventis Belgium NV.2

  1. 1National Bank, annual accounts 2011
  2. 2Belgian Official Gazette, 15-05-2012